• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白Z依赖性蛋白酶抑制剂与蛋白Z的C末端结构域结合。

Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z.

作者信息

Rezaie Alireza R, Bae Jong-Sup, Manithody Chandrashekhara, Qureshi Shabir H, Yang Likui

机构信息

Edward A Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, MO 63104, USA.

出版信息

J Biol Chem. 2008 Jul 18;283(29):19922-6. doi: 10.1074/jbc.M802639200. Epub 2008 May 23.

DOI:10.1074/jbc.M802639200
PMID:18502758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2459281/
Abstract

Protein Z (PZ) is a multidomain vitamin K-dependent plasma protein that functions as a cofactor to promote the inactivation of factor Xa (fXa) by PZ-dependent protease inhibitor (ZPI) by three orders of magnitude. To understand the mechanism by which PZ improves the reactivity of fXa with ZPI, we expressed wild-type PZ, PZ lacking the gamma-carboxyglutamic acid domain (GD-PZ), and a chimeric PZ mutant in which both Gla and EGF-like domains of the molecule were substituted with identical domains of fXa. The ZPI binding and the cofactor function of the PZ derivatives were characterized in both binding and kinetic assays. The binding assay indicated that all PZ derivatives interact with ZPI with a similar dissociation constant (K(D)) of approximately 7 nm. However, the apparent K(D) for the chimeric PZ-mediated ZPI inhibition of fXa was elevated 6-fold on PC/PS vesicles and its capacity to function as a cofactor to accelerate the ZPI inhibition of fXa was also decreased 6-fold. The cofactor activity of GD-PZ was dramatically impaired; however, the deletion mutant exhibited a normal cofactor function in solution. A chimeric activated protein C mutant containing the Gla domain of fXa was susceptible to inhibition by ZPI in the presence of PZ. These results suggest that: (i) the ZPI interactive site of PZ is located within the C-terminal domain of the cofactor and (ii) a specific interaction between the Gla domains of PZ and fXa contributes approximately 6-fold to the acceleration of the ZPI inhibition of fXa on phospholipid membranes.

摘要

蛋白Z(PZ)是一种多结构域的维生素K依赖性血浆蛋白,作为一种辅因子发挥作用,可使PZ依赖性蛋白酶抑制剂(ZPI)对因子Xa(fXa)的灭活作用增强三个数量级。为了了解PZ提高fXa与ZPI反应活性的机制,我们表达了野生型PZ、缺失γ-羧基谷氨酸结构域的PZ(GD-PZ)以及一种嵌合PZ突变体,该突变体分子的Gla和表皮生长因子样结构域均被fXa的相同结构域所取代。通过结合和动力学分析对PZ衍生物的ZPI结合及辅因子功能进行了表征。结合分析表明,所有PZ衍生物与ZPI相互作用的解离常数(K(D))相似,约为7 nM。然而,在PC/PS囊泡上,嵌合PZ介导的ZPI对fXa的抑制作用的表观K(D)升高了6倍,其作为辅因子加速ZPI对fXa抑制作用的能力也降低了6倍。GD-PZ的辅因子活性显著受损;然而,该缺失突变体在溶液中表现出正常的辅因子功能。含有fXa的Gla结构域的嵌合活化蛋白C突变体在PZ存在的情况下易受ZPI的抑制。这些结果表明:(i)PZ的ZPI相互作用位点位于辅因子的C末端结构域内;(ii)PZ和fXa的Gla结构域之间的特异性相互作用使磷脂膜上ZPI对fXa的抑制作用加速约6倍。

相似文献

1
Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z.蛋白Z依赖性蛋白酶抑制剂与蛋白Z的C末端结构域结合。
J Biol Chem. 2008 Jul 18;283(29):19922-6. doi: 10.1074/jbc.M802639200. Epub 2008 May 23.
2
Characterization of the protein Z-dependent protease inhibitor interactive-sites of protein Z.蛋白Z依赖的蛋白酶抑制剂与蛋白Z相互作用位点的表征
Biochim Biophys Acta. 2014 Sep;1844(9):1631-7. doi: 10.1016/j.bbapap.2014.06.011. Epub 2014 Jun 21.
3
Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.作为膜结合型因子 Xa 的抑制剂,丝氨酸蛋白酶抑制剂蛋白 Z 依赖性(serpin protein Z-dependent)蛋白抑制剂(ZPI)的特异性和激活的基础。
J Biol Chem. 2010 Jun 25;285(26):20399-409. doi: 10.1074/jbc.M110.112748. Epub 2010 Apr 28.
4
Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa.蛋白Z依赖性蛋白酶抑制剂与凝血因子Xa反应的动力学特征
J Biol Chem. 2008 Oct 31;283(44):29770-83. doi: 10.1074/jbc.M805214200. Epub 2008 Sep 3.
5
Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.蛋白 Z 依赖性蛋白酶抑制剂(ZPI)是凝血酶原酶功能的一种具有生理意义的抑制物。
J Biol Chem. 2019 May 10;294(19):7644-7657. doi: 10.1074/jbc.RA118.006787. Epub 2019 Mar 27.
6
Thermodynamic and kinetic characterization of the protein Z-dependent protease inhibitor (ZPI)-protein Z interaction reveals an unexpected role for ZPI Lys-239.依赖蛋白Z的蛋白酶抑制剂(ZPI)与蛋白Z相互作用的热力学和动力学特征揭示了ZPI赖氨酸-239的意外作用。
J Biol Chem. 2015 Apr 10;290(15):9906-18. doi: 10.1074/jbc.M114.633479. Epub 2015 Feb 20.
7
Engineering a protein Z-dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment.工程化蛋白 Z 依赖性蛋白酶抑制剂 (ZPI) 突变体作为 ZPI 抗凝功能的新型拮抗剂用于血友病治疗。
J Thromb Haemost. 2019 Oct;17(10):1655-1660. doi: 10.1111/jth.14610. Epub 2019 Sep 5.
8
Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X.蛋白Z依赖性抑制剂复合物的晶体结构揭示了蛋白Z如何作为辅助因子在膜上抑制因子X发挥作用。
Blood. 2009 Oct 22;114(17):3662-7. doi: 10.1182/blood-2009-04-210021. Epub 2009 Jun 15.
9
Phosphatidylserine and Phosphatidylethanolamine Bind to Protein Z Cooperatively and with Equal Affinity.磷脂酰丝氨酸和磷脂酰乙醇胺以相同亲和力协同结合至蛋白Z。
PLoS One. 2016 Sep 1;11(9):e0161896. doi: 10.1371/journal.pone.0161896. eCollection 2016.
10
Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.鉴定与蛋白Z依赖性蛋白酶抑制剂相互作用至关重要的凝血因子Xa残基:抑制作用需要活性位点和外位点相互作用。
J Biol Chem. 2005 Sep 23;280(38):32722-8. doi: 10.1074/jbc.M505517200. Epub 2005 Aug 3.

引用本文的文献

1
Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.抑制蛋白 Z 依赖性的因子 Xa 抑制可改善血友病 A 的凝血功能。
J Thromb Haemost. 2019 Jan;17(1):149-156. doi: 10.1111/jth.14337. Epub 2018 Dec 16.
2
Characterization of Protein Z-Dependent Protease Inhibitor/Antithrombin Chimeras Provides Insight into the Serpin Specificity of Coagulation Proteases.蛋白质Z依赖性蛋白酶抑制剂/抗凝血酶嵌合体的特性研究为深入了解凝血蛋白酶的丝氨酸蛋白酶抑制剂特异性提供了线索。
ACS Omega. 2017 Jul 31;2(7):3276-3283. doi: 10.1021/acsomega.7b00606. Epub 2017 Jul 7.
3
Calcification in dermal fibroblasts from a patient with GGCX syndrome accompanied by upregulation of osteogenic molecules.来自一名伴有成骨分子上调的GGCX综合征患者的真皮成纤维细胞中的钙化。
PLoS One. 2017 May 11;12(5):e0177375. doi: 10.1371/journal.pone.0177375. eCollection 2017.
4
Phosphatidylserine and Phosphatidylethanolamine Bind to Protein Z Cooperatively and with Equal Affinity.磷脂酰丝氨酸和磷脂酰乙醇胺以相同亲和力协同结合至蛋白Z。
PLoS One. 2016 Sep 1;11(9):e0161896. doi: 10.1371/journal.pone.0161896. eCollection 2016.
5
Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.抑制性丝氨酸蛋白酶抑制剂。对其折叠、聚合、调节和清除的新见解。
Biochem J. 2016 Aug 1;473(15):2273-93. doi: 10.1042/BCJ20160014.
6
Characterization of the protein Z-dependent protease inhibitor interactive-sites of protein Z.蛋白Z依赖的蛋白酶抑制剂与蛋白Z相互作用位点的表征
Biochim Biophys Acta. 2014 Sep;1844(9):1631-7. doi: 10.1016/j.bbapap.2014.06.011. Epub 2014 Jun 21.
7
Liver-specific γ-glutamyl carboxylase-deficient mice display bleeding diathesis and short life span.肝脏特异性γ-谷氨酰羧化酶缺陷型小鼠表现出出血素质和短寿命。
PLoS One. 2014 Feb 10;9(2):e88643. doi: 10.1371/journal.pone.0088643. eCollection 2014.
8
Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer.人胃癌组织中蛋白 Z/蛋白 Z 依赖性蛋白酶抑制剂系统。
Ann Hematol. 2014 May;93(5):779-84. doi: 10.1007/s00277-013-1941-8. Epub 2013 Oct 26.
9
Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.39 环残基限制了因子 IXa 的血浆抑制剂特异性。
J Biol Chem. 2013 May 3;288(18):12692-8. doi: 10.1074/jbc.M113.459347. Epub 2013 Mar 25.
10
Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein Z.蛋白 Z 依赖性蛋白酶抑制剂 (ZPI) 的催化激活的结构基础
Blood. 2012 Aug 23;120(8):1726-33. doi: 10.1182/blood-2012-03-419598. Epub 2012 Jul 11.

本文引用的文献

1
FRET studies with factor X mutants provide insight into the topography of the membrane-bound factor X/Xa.对因子X突变体进行的荧光共振能量转移(FRET)研究有助于深入了解膜结合型因子X/Xa的拓扑结构。
Biochem J. 2007 Nov 1;407(3):427-33. doi: 10.1042/BJ20070735.
2
Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors.凝血酶-血栓调节蛋白-蛋白C复合物的钙结合位点:血小板因子4对维生素K依赖的凝血因子激活作用的潜在影响。
Thromb Haemost. 2007 Jun;97(6):899-906. doi: 10.1160/th06-12-0697.
3
Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity.凝血因子XIa自溶环中碱性氨基酸对丝氨酸蛋白酶抑制剂特异性的作用。
Biochemistry. 2006 Aug 8;45(31):9427-33. doi: 10.1021/bi060820+.
4
Down-regulation of factor IXa in the factor Xase complex by protein Z-dependent protease inhibitor.蛋白Z依赖性蛋白酶抑制剂对凝血因子X酶复合物中凝血因子IXa的下调作用。
J Biol Chem. 2005 Oct 7;280(40):33819-25. doi: 10.1074/jbc.M506502200. Epub 2005 Aug 10.
5
Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.鉴定与蛋白Z依赖性蛋白酶抑制剂相互作用至关重要的凝血因子Xa残基:抑制作用需要活性位点和外位点相互作用。
J Biol Chem. 2005 Sep 23;280(38):32722-8. doi: 10.1074/jbc.M505517200. Epub 2005 Aug 3.
6
Mutations within the protein Z-dependent protease inhibitor gene are associated with venous thromboembolic disease: a new form of thrombophilia.蛋白Z依赖性蛋白酶抑制剂基因内的突变与静脉血栓栓塞性疾病相关:一种新的易栓症形式。
Br J Haematol. 2004 Oct;127(2):190-4. doi: 10.1111/j.1365-2141.2004.05189.x.
7
Role of the N-terminal epidermal growth factor-like domain of factor X/Xa.凝血因子X/Xa的N端表皮生长因子样结构域的作用
J Biol Chem. 2004 Jun 4;279(23):24189-96. doi: 10.1074/jbc.M402302200. Epub 2004 Apr 6.
8
Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.凝血因子X/Xa的70-80环突变体的酶原性和酶活性
Protein Sci. 2004 Feb;13(2):431-42. doi: 10.1110/ps.03406904.
9
Protein Z influences the prothrombotic phenotype in Factor V Leiden patients.蛋白Z影响莱顿因子V突变患者的血栓前表型。
Thromb Res. 2002 May 15;106(4-5):183-5. doi: 10.1016/s0049-3848(02)00181-0.
10
Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor.蛋白Z在血浆中与蛋白Z依赖性蛋白酶抑制剂以复合物的形式循环。
Thromb Haemost. 2001 Apr;85(4):655-60.